2 min read

Evaluating Existing Safety Surveillance Regulations for Drug Development

UBC's pharmacovigilance experts compare current safety regulations in Advances in Therapy.

UBC is proud to announce the publication of members of our pharmacovigilance team in Advances in Therapy. The article – “Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations” – features contributions from Safety Scientists Christopher Henry, Alix Garcia, Chysanthi Samara, Safety Physician Laure Valotton, and Pharmacovigilance Physician Leader Alexis Pincon.

Safety surveillance during drug development is a globally recognized necessity. However, different regions and countries have different standards for what is required, leading to safety processes that need to be harmonized. This research analyzes the current regulations and seeks out solutions to increase the global viability of safety surveillance during drug development.

To read the full paper, click here.

UBC’s pharmacovigilance team excels at handling every aspect of your safety requirements at all stages of the drug lifecycle. Our commitment to Patients First has driven us to balance high-tech solutions with a personalized, experienced touch in our services. To learn more about UBC’s physician-driven pharmacovigilance offering, click here. To contact our team directly, click here.

Other Recent Posts

1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
5 min read

UBC Successfully Implemented REMS Administration Software During HL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.